Phase 2 Lung Cancer Trial, Not Yet Recruiting
voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice
Who may and may not be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who may be able to join
- People who are willing and able to sign a written consent form agreeing to take part.
- People aged 18 to 75 years (inclusive), of any gender.
- People with a good general health and activity level, rated 0 or 1 on a standard performance scale used by doctors (confirm with trial site).
- People who have been diagnosed with non-small cell lung cancer through a tissue or cell sample, at a stage that is considered operable (clinical stage II to IIIB with a specific tumour and lymph node classification, according to an international cancer staging system).
- People who have not previously received any treatment for their cancer.
- People whose cancer does not have specific known genetic changes called EGFR sensitive mutations or ALK gene translocations.
Who may not be able to join
Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.
- People whose lung cancer is a type called large cell carcinoma, mixed-cell lung cancer, or a mixture that includes small cell lung cancer.
- People whose cancer has spread to other parts of the body or cannot be surgically removed.
- People who received certain local treatments for cancer lesions, immune-boosting therapies, or specific herbal or traditional Chinese medicines within a short period before the trial starts (the timeframes vary by treatment type — confirm with trial site).
- People who had a serious infection in the four weeks before the trial starts, including infections requiring hospitalisation, blood poisoning, or severe pneumonia; or people currently being treated with infection-fighting medicines taken throughout the body within two weeks before the trial starts (not including ongoing hepatitis B or C antiviral treatment).
- People who had major surgery or a serious injury in the four weeks before the trial starts, who are planned to have major surgery in the four weeks after the trial starts, or who had minor local surgery in the three days before the trial starts (some specific exceptions may apply — confirm with trial site).
- People with a history of serious bleeding problems or issues with blood clotting; people who have had significant bleeding episodes in the month before the trial starts (such as gastrointestinal bleeding or coughing up blood); or people who have been taking ongoing blood-thinning or anti-clotting medicines in the ten days before the trial starts.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +86139 1015 4426
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Primary endpoints
Pathological Complete Response（pCR）rate
Can't join this trial?
Data last synced from ClinicalTrials.gov: 24 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.